Mingyue Liu

发表

Which Is the Most Appropriate PI3K Inhibitor for Breast Cancer Patients with or without PIK3CA Status Mutant? A Systematic Review and Network Meta-Analysis

Yingshi Zhang, Qingchun Zhao, L. Jian, 2020, BioMed research international.

DZW-310, a novel phosphoinositide 3-kinase inhibitor, attenuates the angiogenesis and growth of hepatocellular carcinoma cells via PI3K/AKT/mTOR axis.

Qiong Wu, Xiangbo Xu, Xiaochun Qin, 2022, Biochemical pharmacology.

DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer

Yingshi Zhang, Chang Xu, Qiong Wu, 2022, Frontiers in Oncology.

Cimigenoside functions as a novel γ-secretase inhibitor and inhibits the proliferation or metastasis of human breast cancer cells by γ-secretase/Notch axis.

Qingchun Zhao, Jincai Lu, Chongning Lv, 2021, Pharmacological research.

Discovery of novel tacrine derivatives as potent antiproliferative agents with CDKs inhibitory property.

Limeng Wu, Qingchun Zhao, Xin Liu, 2022, Bioorganic chemistry.

Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.

Fuhai Hui, Tian-shu Ren, Qingchun Zhao, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer.

Nan Wang, Chang Xu, Chengze Zhu, 2022, European journal of medicinal chemistry.

ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT/mTOR Pathway

Chang Xu, Xiang-bo Xu, Xiaochun Qin, 2022, Frontiers in Oncology.

Does coffee, tea and caffeine consumption reduce the risk of incident breast cancer? A systematic review and network meta-analysis

Yingshi Zhang, Yue Yang, Xiang Li, 2021, Public Health Nutrition.

Design, synthesis, and biological evaluation of β-carboline 1,3,4-oxadiazole based hybrids as HDAC inhibitors with potential antitumor effects.

H. Ding, Cheng Zhu, Limeng Wu, 2022, Bioorganic & medicinal chemistry letters.

DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis

L. Jian, Shu Wang, Mingyue Liu, 2022, Frontiers in Oncology.

Facile synthesis of C1-substituted β-carbolines as CDK4 inhibitors for the treatment of cancer.

H. Ding, Ya-Ting Huang, Deping Li, 2022, Bioorganic chemistry.

Discovery of novel benzofuro[3,2-b]quinoline derivatives as dual CDK2/Topo I inhibitors.

Chang Xu, Cheng Zhu, Limeng Wu, 2022, Bioorganic chemistry.

Dual blocking of PI3K and mTOR signaling by DHW‐221, a novel benzimidazole derivative, exerts antitumor activity in human non‐small cell lung cancer

Qingchun Zhao, H. Ding, Qiong Wu, 2021, Clinical and translational medicine.